Societal CDMO, Inc. announced the signing of a master service agreement (MSA) with CivicaScript. This agreement covers an initial project supporting a generic drug candidate that is moving through development and registration efforts, with the potential to expand to include support of additional CivicaScript programs. Under terms of the agreement, Societal CDMO will execute a range of services including analytic method and tech transfer, formulation development, process development, and non-GMP batch manufacturing. The work will then culminate in registration scale batch manufacturing to produce clinical trial materials intended for registration with the U.S. Food and Drug Administration.

This will include registration batch bottle packaging, labeling, and clinical supply distribution.